• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal

    1/29/24 9:48:40 AM ET
    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Catalog/Specialty Distribution
    Consumer Discretionary
    Auto Manufacturing
    Consumer Discretionary
    Get the next $AMZN alert in real time by email

    U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 25 points on Monday.

    Following the market opening Monday, The Dow traded up 0.07% to 38,134.80 while the NASDAQ rose 0.04% to 15,461.42. The S&P 500 also fell, dropping, 0.04% to 4,893.17.

    Check This Out: American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday

     

    Leading and Lagging Sectors

     

    Consumer discretionary shares rose by 0.2% on Monday.

    In trading on Monday, communication services shares fell by 0.3%.

     

    Top Headline

     

    Amazon.Com Inc (NASDAQ:AMZN) and iRobot Corp (NASDAQ:IRBT) mutually agreed to terminate their $1.7 billion merger deal.

    This deal would have allowed Amazon to invest in continued innovation by iRobot and support iRobot in lowering prices on product customers.

     

    Equities Trading UP

     

    Palisade Bio, Inc. (NASDAQ:PALI) shares shot up 132% to $1.23 after the company requested the withdrawal of a recently filed registration statement. Also, the company announced preclinical data of its lead program PALI-2108 at the 2024 Crohn's & Colitis Congress.

    Shares of OneMedNet Corporation (NASDAQ:ONMD) got a boost, surging 91% to $1.0210. OneMedNet announced participation as an exhibitor at the 15ᵗʰ Annual SCOPE Summit.

    Revelation Biosciences, Inc. (NASDAQ:REVB) shares were also up, gaining 89% to $18.64.

     

    Equities Trading DOWN

     

    Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares dropped 67% to $1.43 after the company announced pricing of a roughly $9 million public offering.

    Shares of Arrival (NASDAQ:ARVL) were down 24% to $0.56.

    SMX (Security Matters) Public Limited Company (NYSE:SMX) was down, falling 21% to $0.3396 after gaining around 83% on Friday.

    Also Check This Out: Top 3 Consumer Stocks That May Crash In January

     

    Commodities

     

    In commodity news, oil traded down 1.2% to $77.06 while gold traded up 0.6% at $2,030.10.

    Silver traded down 0.7% to $23.03 on Monday while copper rose 0.1% to $3.8555.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 rose 0.1%, London’s FTSE 100 rose 0.1% while Spain’s IBEX 35 Index fell 0.6% The German DAX fell 0.4% French CAC 40 slipped 0.1% while Italy’s FTSE MIB Index fell 0.7%.

    The Credit Union Consumer Sentiment Index in Ireland climbed to 74.2 in January versus a reading of 62.4 in December.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Monday, with Japan’s Nikkei 225 gaining 0.77%, Hong Kong’s Hang Seng Index gaining 0.78% and China’s Shanghai Composite Index falling 0.92%. India’s S&P BSE Sensex, meanwhile, jumped 1.74%.

    Profits earned by Chinese industrial firms declined 2.3% year-over-year to CNY 7,685.83 billion last year. The Domestic Supply Price Index in Singapore declined 1.1% year-over-year in December, while Malaysia’s producer prices fell 1.3% year-over-year in December.

     

    Economics

     

    The Dallas Fed Manufacturing index will be released at 10:00 a.m. ET.

    Now Read This: Meta Platforms, Caterpillar And 2 Other Stocks Insiders Are Selling

     

    Get the next $AMZN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMZN
    $ARVL
    $IRBT
    $ONMD

    CompanyDatePrice TargetRatingAnalyst
    Amazon.com Inc.
    $AMZN
    2/6/2026$300.00 → $280.00Buy
    Monness Crespi & Hardt
    Amazon.com Inc.
    $AMZN
    2/6/2026$175.00Buy → Neutral
    DA Davidson
    Amazon.com Inc.
    $AMZN
    2/2/2026$300.00 → $315.00Mkt Outperform
    Citizens JMP
    Amazon.com Inc.
    $AMZN
    1/28/2026$305.00 → $315.00Outperform
    Oppenheimer
    Amazon.com Inc.
    $AMZN
    1/28/2026$303.00 → $308.00Overweight
    KeyBanc Capital Markets
    Amazon.com Inc.
    $AMZN
    1/27/2026$295.00 → $300.00Buy
    Stifel
    Amazon.com Inc.
    $AMZN
    1/27/2026$303.00 → $286.00Buy
    BofA Securities
    Amazon.com Inc.
    $AMZN
    1/15/2026$275.00 → $260.00Outperform
    Raymond James
    More analyst ratings

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

    For Immediate Release: February 18, 2022 Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in

    2/18/22 8:06:10 PM ET
    $ARVL
    Auto Manufacturing
    Consumer Discretionary

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Worldwide Amazon Stores Herrington Douglas J converted options into 11,959 shares and sold $948,990 worth of shares (4,784 units at $198.37), increasing direct ownership by 1% to 512,109 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    2/18/26 6:16:06 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Gorelick Jamie S converted options into 2,677 shares, increasing direct ownership by 7% to 40,794 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    2/18/26 6:05:51 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Weeks Wendell P converted options into 1,816 shares, increasing direct ownership by 4% to 46,216 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    2/18/26 5:57:32 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Monness Crespi & Hardt reiterated coverage on Amazon with a new price target

    Monness Crespi & Hardt reiterated coverage of Amazon with a rating of Buy and set a new price target of $280.00 from $300.00 previously

    2/6/26 8:23:18 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon downgraded by DA Davidson with a new price target

    DA Davidson downgraded Amazon from Buy to Neutral and set a new price target of $175.00

    2/6/26 8:06:19 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Citizens JMP reiterated coverage on Amazon with a new price target

    Citizens JMP reiterated coverage of Amazon with a rating of Mkt Outperform and set a new price target of $315.00 from $300.00 previously

    2/2/26 8:12:32 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/21/26 4:05:24 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Williams Donald Allen bought $9,400 worth of shares (5,000 units at $1.88), increasing direct ownership by 687% to 5,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/13/26 9:43:07 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Medical Officer Yu Jeffrey converted options into 2,307,549 shares, bought $959,586 worth of shares (2,010,479 units at $0.48) and was granted 245,000 shares, increasing direct ownership by 165% to 7,326,223 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    11/26/25 9:56:08 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    SEC Filings

    View All

    SEC Form 6-K filed by SMX (Security Matters) Public Limited Company

    6-K - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    2/19/26 9:49:50 AM ET
    $SMX
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Revelation Biosciences Inc.

    SCHEDULE 13G/A - REVELATION BIOSCIENCES, INC. (0001810560) (Subject)

    2/17/26 9:37:07 PM ET
    $REVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form F-1 filed by SMX (Security Matters) Public Limited Company

    F-1 - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    2/17/26 4:42:01 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    M2i Global, along with Volato Group, and SMX Execute Collaboration Agreement for Pilot Initiative to Enable Secure Tracking and Traceable Critical Minerals Commerce Through CAINO and the M2i Metals Marketplace

    Agreement is first step to advance critical minerals shipment assurance, digital chain-of-custody, and authenticated marketplace transactions Atlanta, GA and Reno, NV, Feb. 19, 2026 (GLOBE NEWSWIRE) -- M2i Global, Inc. ("M2i," the "Company," "we," "our" or "us") (OTCQB:MTWO), a company specializing in the development and execution of a complete global value supply chain for critical minerals, along with Volato Group, Inc. ("Volato") (NYSE:SOAR), a technology-driven company, is pleased to announce that it has entered into a Strategic Collaboration Agreement with SMX (Security Matters) PLC (NASDAQ:SMX) ("SMX"), a publicly traded company focused on supply chain traceability and integrity sol

    2/19/26 9:00:00 AM ET
    $SMX
    $SOAR
    Industrial Machinery/Components
    Technology
    Transportation Services
    Consumer Discretionary

    Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board

    Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn's disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 Carlsbad, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company advancing next-generation, once-daily oral PDE4 inhibitor prodrugs engineered for targeted delivery to the terminal ileum and colon, today announced the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board (CAB). Dr. Verstockt is an internationally recognized expert in inflammatory bowel disease (IBD) and a leader in precisi

    2/17/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Prior Year by More Than 4.1X and Accelerating Subscription Transition

    MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leader in AI-powered Real-World Data (RWD), today announced record bookings in 2025 of data-delivery agreements totaling $2.79 million of contract value, exceeding 2024 bookings by more than four times (4X). The milestone reflects increasing deal size, strong enterprise demand, and meaningful progress toward a recurring subscription model. The Company also provides an update on product offering heading into 2026. 2025 Booking Highlights Total Bookings: $2.79 million in contract value signed in 2025, 4.1X more than prior fiscal yearLarger Deal Sizes:

    2/12/26 9:00:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Leadership Updates

    Live Leadership Updates

    View All

    Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board

    Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn's disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 Carlsbad, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company advancing next-generation, once-daily oral PDE4 inhibitor prodrugs engineered for targeted delivery to the terminal ileum and colon, today announced the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board (CAB). Dr. Verstockt is an internationally recognized expert in inflammatory bowel disease (IBD) and a leader in precisi

    2/17/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

    Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's disease, and late-stage clinical trial design Appointments strengthen Palisade Bio's clinical strategy as PALI-2108 advances toward Phase 2 development in ulcerative colitis and fibrostenotic Crohn's disease, with a Phase 2 UC IND submission planned for the first half of 2026 Carlsbad, CA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today an

    1/29/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Financials

    Live finance-specific insights

    View All

    Amazon.com Announces Fourth Quarter Results

    Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its fourth quarter ended December 31, 2025. Fourth Quarter 2025 Net sales increased 14% to $213.4 billion in the fourth quarter, compared with $187.8 billion in fourth quarter 2024. Excluding the $2.8 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with fourth quarter 2024. North America segment sales increased 10% year-over-year to $127.1 billion. International segment sales increased 17% year-over-year to $50.7 billion, or increased 11% excluding changes in foreign exchange rates. AWS segment sales increased 24% year-over

    2/5/26 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon.com to Webcast Fourth Quarter 2025 Financial Results Conference Call

    Amazon.com, Inc. (NASDAQ:AMZN) announced today that it will hold a conference call to discuss its fourth quarter 2025 financial results on Thursday, February 5, 2026, at 2:00 p.m. PT/5:00 p.m. ET. The event will be webcast live, and the audio and associated slides will be available for at least three months thereafter at www.amazon.com/ir. View source version on businesswire.com: https://www.businesswire.com/news/home/20260122132654/en/ Amazon.com Public Relations [email protected] amazon.com/ir

    1/22/26 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    OneMedNet Reports 815% Bookings Increase and 4.5X increase in Inbound Demand

    MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leader in AI-powered Real-World Data (RWD), announced its financial results for the third quarter ended September 30, 2025 and operational highlights. Third Quarter Financial Highlights Bookings:  $1.1M in third quarter 2025 bookings, an 815% increase compared to third quarter of 2024.Private Placements: Successfully completed an additional $0.5M private placement of common stock from an insider, providing further investment towards strategic objectives.Further Improved Balance Sheet: Continuing with its efforts first reported at the end of the second qu

    11/17/25 7:45:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Palisade Bio Inc.

    SC 13G - PALISADE BIO, INC. (0001357459) (Subject)

    11/14/24 3:35:13 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by iRobot Corporation

    SC 13G - IROBOT CORP (0001159167) (Subject)

    11/14/24 12:01:27 PM ET
    $IRBT
    Consumer Electronics/Appliances
    Consumer Discretionary

    SEC Form SC 13G filed by OneMedNet Corp

    SC 13G - OneMedNet Corp (0001849380) (Subject)

    11/12/24 3:35:37 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care